These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 7568285

  • 1. Dynamics of prolactin secretion from diethylstilbestrol-induced rat prolactinoma tissue in vitro.
    Maas DL, Martinson DR, Erdmann MD, Wahle JS, Hagen TC.
    Proc Soc Exp Biol Med; 1995 Nov; 210(2):150-5. PubMed ID: 7568285
    [Abstract] [Full Text] [Related]

  • 2. Vasoactive intestinal polypeptide antiserum affects rat prolactin mRNA in 40-day but not 110-day diethylstilbestrol-induced prolactinoma tissue.
    Maas DL, Meier DA, Wahle JS, Martinson DR, Hagen TC.
    Mol Cell Neurosci; 1994 Apr; 5(2):182-8. PubMed ID: 8032686
    [Abstract] [Full Text] [Related]

  • 3. [A study on the prolactin releasing mechanism using an in vitro perfusion system with a cell column of cultured rat anterior pituitary cells].
    Kageyama J.
    Nihon Naibunpi Gakkai Zasshi; 1984 Oct 20; 60(10):1243-54. PubMed ID: 6440813
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells.
    Apfelbaum ME.
    Neuroendocrinology; 1998 Jan 20; 67(1):45-50. PubMed ID: 9485168
    [Abstract] [Full Text] [Related]

  • 6. Sexual dimorphism in diethylstilbestrol-induced prolactin pituitary tumors in F344 rats.
    Piroli GG, Torres A, Pietranera L, Grillo CA, Ferrini MG, Lux-Lantos V, Aoki A, De Nicola AF.
    Neuroendocrinology; 2000 Aug 20; 72(2):80-90. PubMed ID: 10971143
    [Abstract] [Full Text] [Related]

  • 7. Vasoactive intestinal polypeptide and thyrotropin-releasing hormone stimulate newly synthesized, not stored, prolactin.
    Maas DL, Arnaout MA, Martinson DR, Erdmann MD, Hagen TC.
    Endocrinology; 1991 Feb 20; 128(2):1015-20. PubMed ID: 1899215
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effect of thalidomide on the growth, secretory function and angiogenesis of estrogen-induced prolactinoma in Fischer 344 rats.
    Stepień H, Lawnicka H, Mucha S, Wagrowska-Danilewicz M, Stepień B, Siejka A, Komorowski J.
    Life Sci; 2006 Sep 27; 79(18):1741-8. PubMed ID: 16846617
    [Abstract] [Full Text] [Related]

  • 9. The effect of dopamine antagonists and/or VIP on TRH- or VIP-induced prolactin release in estrogen- and progesterone-treated ovariectomized rats.
    Haisenleder DJ, Moy JA, Gala RR, Lawson DM.
    Proc Soc Exp Biol Med; 1988 Mar 27; 187(3):341-9. PubMed ID: 3126503
    [Abstract] [Full Text] [Related]

  • 10. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
    Christian HC, Chapman LP, Morris JF.
    J Neuroendocrinol; 2007 Aug 27; 19(8):605-13. PubMed ID: 17620102
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pituitary vasoactive intestinal peptide regulates prolactin secretion in the hypothyroid rat.
    Lam KS, Reichlin S.
    Neuroendocrinology; 1989 Nov 27; 50(5):524-8. PubMed ID: 2514393
    [Abstract] [Full Text] [Related]

  • 13. Interaction between substance P and TRH in the control of prolactin release.
    Duvilanski BH, Pisera D, Seilicovich A, del Carmen Díaz M, Lasaga M, Isovich E, Velardez MO.
    J Endocrinol; 2000 Aug 27; 166(2):373-80. PubMed ID: 10927626
    [Abstract] [Full Text] [Related]

  • 14. Perifusion studies of bromocriptine-treated and untreated macroprolactinomas: effects of dopamine, bromocriptine and TRH.
    Bevan JS, Burke CW.
    Clin Endocrinol (Oxf); 1989 Jun 27; 30(6):667-80. PubMed ID: 2512041
    [Abstract] [Full Text] [Related]

  • 15. Interaction between vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI) in stimulating the secretion of prolactin from rat anterior pituitary cells in vitro.
    Inoue T, Kato Y, Koshiyama H, Yanaihara N, Imura H.
    Neurosci Lett; 1988 Mar 10; 85(3):363-9. PubMed ID: 3362424
    [Abstract] [Full Text] [Related]

  • 16. Role of neuromedin B in the in vitro thyrotropin release in response to thyrotropin-releasing hormone from anterior pituitaries of eu-, hypo-, and hyperthyroid rats.
    Pazos-Moura CC, Moura EG, Rettori V, Polak J, McCann SM.
    Proc Soc Exp Biol Med; 1996 Apr 10; 211(4):353-8. PubMed ID: 8618941
    [Abstract] [Full Text] [Related]

  • 17. Calcitonin inhibits basal and thyrotropin-releasing hormone-induced release of prolactin from anterior pituitary cells: evidence for a selective action exerted proximal to secretagogue-induced increases in cytosolic Ca2+.
    Shah GV, Wang W, Grosvenor CE, Crowley WR.
    Endocrinology; 1990 Aug 10; 127(2):621-8. PubMed ID: 2115431
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.